Go to content
UR Home

Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

URN to cite this document:
Stuber, G. ; Leder, G. H. ; Storkus, W. T. ; Lotze, M. T. ; Modrow, Susanne ; Székely, L. ; Wolf, Hans J. ; Klein, E. ; Kärre, K. ; Klein, G.
Date of publication of this fulltext: 06 Apr 2011 07:44


Mutations of the p53 gene are the most frequently observed genetic changes in human cancers; often leading to an overexpression of the wild-type (wt) p53 protein. Demonstrable T cell reactivity against tumor cells overexpressing wt or mutant p53-derived peptides could support the application of such epitopes in cancer immunotherapies. As the binding of peptide to MHC class I molecules is a ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons